These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 26101805)

  • 1. Nonparametric randomization-based covariate adjustment for stratified analysis of time-to-event or dichotomous outcomes.
    Hussey MA; Koch GG; Preisser JS; Saville BR
    J Biopharm Stat; 2016; 26(3):579-89. PubMed ID: 26101805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimating covariate-adjusted log hazard ratios in randomized clinical trials using cox proportional hazards models and nonparametric randomization based analysis of covariance.
    Saville BR; Koch GG
    J Biopharm Stat; 2013 Mar; 23(2):477-90. PubMed ID: 23437952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonparametric covariate adjustment in estimating hazard ratios.
    Jiang H; Kulkarni PM; Wang Y; Mallinckrodt CH
    Pharm Stat; 2016; 15(1):46-53. PubMed ID: 26610282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complementary nonparametric analysis of covariance for logistic regression in a randomized clinical trial setting.
    Tangen CM; Koch GG
    J Biopharm Stat; 1999 Mar; 9(1):45-66. PubMed ID: 10091909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Issues for covariance analysis of dichotomous and ordered categorical data from randomized clinical trials and non-parametric strategies for addressing them.
    Koch GG; Tangen CM; Jung JW; Amara IA
    Stat Med; 1998 Aug 15-30; 17(15-16):1863-92. PubMed ID: 9749453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitivity analysis for missing outcomes in time-to-event data with covariate adjustment.
    Zhao Y; Saville BR; Zhou H; Koch GG
    J Biopharm Stat; 2016; 26(2):269-79. PubMed ID: 25635808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-parametric covariance methods for incidence density analyses of time-to-event data from a randomized clinical trial and their complementary roles to proportional hazards regression.
    Tangen CM; Koch GG
    Stat Med; 2000 Apr; 19(8):1039-58. PubMed ID: 10790679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomization-based adjustment of multiple treatment hazard ratios for covariates with missing data.
    Lam D; Koch GG; Preisser JS; Saville BR; Hussey MA
    J Biopharm Stat; 2017; 27(3):373-386. PubMed ID: 28281895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonparametric analysis of covariance for hypothesis testing with logrank and Wilcoxon scores and survival-rate estimation in a randomized clinical trial.
    Tangen CM; Koch GG
    J Biopharm Stat; 1999 May; 9(2):307-38. PubMed ID: 10379696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomization-based nonparametric methods for the analysis of multicentre trials.
    LaVange LM; Durham TA; Koch GG
    Stat Methods Med Res; 2005 Jun; 14(3):281-301. PubMed ID: 15969304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The type I error and power of non-parametric logrank and Wilcoxon tests with adjustment for covariates--a simulation study.
    Jiang H; Symanowski J; Paul S; Qu Y; Zagar A; Hong S
    Stat Med; 2008 Dec; 27(28):5850-60. PubMed ID: 18759373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-parametric analysis of covariance for confirmatory randomized clinical trials to evaluate dose-response relationships.
    Tangen CM; Koch GG
    Stat Med; 2001 Sep 15-30; 20(17-18):2585-607. PubMed ID: 11523071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized controlled trials with time-to-event outcomes: how much does prespecified covariate adjustment increase power?
    Hernández AV; Eijkemans MJ; Steyerberg EW
    Ann Epidemiol; 2006 Jan; 16(1):41-8. PubMed ID: 16275011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restricted mean survival time: Does covariate adjustment improve precision in randomized clinical trials?
    Karrison T; Kocherginsky M
    Clin Trials; 2018 Apr; 15(2):178-188. PubMed ID: 29502444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitivity analysis for missing dichotomous outcome data in multi-visit randomized clinical trial with randomization-based covariance adjustment.
    Li S; Koch GG; Preisser JS; Lam D; Sanchez-Kam M
    J Biopharm Stat; 2017; 27(3):387-398. PubMed ID: 28281937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Covariate adjustment in randomized controlled trials with dichotomous outcomes increases statistical power and reduces sample size requirements.
    Hernández AV; Steyerberg EW; Habbema JD
    J Clin Epidemiol; 2004 May; 57(5):454-60. PubMed ID: 15196615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonparametric tests for stratum effects in the Cox model.
    Sun J; Yang I
    Lifetime Data Anal; 2000 Dec; 6(4):321-30. PubMed ID: 11190602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Issues for stratified randomization based on a factor derived from a continuous baseline variable.
    Qu Y
    Pharm Stat; 2011; 10(3):232-5. PubMed ID: 20922820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of time to event outcomes in randomized controlled trials by generalized additive models.
    Argyropoulos C; Unruh ML
    PLoS One; 2015; 10(4):e0123784. PubMed ID: 25906075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On proportional hazards assumption under the random effects models.
    Xu R; Gamst A
    Lifetime Data Anal; 2007 Sep; 13(3):317-32. PubMed ID: 17638076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.